Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesChemical Genomics Identifies the Unfolded Protein Response as a Target for Selective Cancer Cell Killing during Glucose Deprivation
Cancer Research, 05/18/09
Saito S et al. - The findings show that disrupting the UPR during glucose deprivation could be an attractive approach for selective cancer cell killing and could provide a chemical genomic basis for developing UPR-targeting drugs against solid tumors.
Related Articles
Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody
British Journal of Cancer, 12/03/09
Relevance Score: 83%
Expression of IL-13Ralpha2 in liver cancer cells and its effect on targeted therapy of liver cancer
Journal of Cancer Research & Clinical Oncology, 11/23/09
Relevance Score: 82%
New Screening Tool Identifies Chemicals That May Destroy Cancer Stem Cells
JAMA, 11/12/09
Relevance Score: 81%
Identification of Compounds Selectively Killing Multidrug-Resistant Cancer Cells
Cancer Research, 11/02/09
Relevance Score: 79%
Menthol induces cell death via the TRPM8 channel in the human bladder cancer cell line T24
Oncology (Karger), 12/03/09
Relevance Score: 71%
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnostic Accuracy of rhTSH Test with Neck Ultrasonography in Differentiated Thyroid Cancer Follow-up
Experimental and Clinical Endocrinology & Diabetes, 12/16/09
Fas Ligand (FasL, Apo-1L/CD95L) Expression and Clinical Outcome in Papillary Microcarcinoma and Papillary Thyroid Carcinomas with Diameter Smaller than 1.5 Centimeters
Experimental and Clinical Endocrinology & Diabetes, 12/16/09
Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer
Current Opinion in Oncology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor